These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20195614)

  • 1. [Methods for estimating personal costs of disease using retinal diseases as an example].
    Porz G; Scholl HP; Holz FG; Finger RP
    Ophthalmologe; 2010 Mar; 107(3):216-20, 222. PubMed ID: 20195614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
    Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
    Chuvarayan Y; Finger RP; Köberlein-Neu J
    Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications].
    Pauleikhoff D; Scheider A; Wiedmann P; Gelisken F; Scholl HP; Roider I; Mohr A; Zlateva G; Xu X
    Ophthalmologe; 2009 Mar; 106(3):242-51. PubMed ID: 18709375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of illness of neovascular age-related macular degeneration in Canada.
    Cruess A; Zlateva G; Xu X; Rochon S
    Can J Ophthalmol; 2007 Dec; 42(6):836-43. PubMed ID: 18026200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
    Lamoureux EL; Pallant JF; Pesudovs K; Tennant A; Rees G; O'Connor PM; Keeffe JE
    Ophthalmic Epidemiol; 2008; 15(2):105-13. PubMed ID: 18432494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative cost of a line of vision in age-related macular degeneration.
    Smiddy WE
    Ophthalmology; 2007 May; 114(5):847-54. PubMed ID: 17306878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age related macular degeneration and visual disability.
    Christoforidis JB; Tecce N; Dell'Omo R; Mastropasqua R; Verolino M; Costagliola C
    Curr Drug Targets; 2011 Feb; 12(2):221-33. PubMed ID: 20887239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy.
    Bandello F; Augustin A; Sahel JA; Benhaddi H; Negrini C; Hieke K; Berdeaux GH;
    Drugs Aging; 2008; 25(3):255-68. PubMed ID: 18331076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of illness of bilateral neovascular age-related macular degeneration in Spain.
    Ruiz-Moreno JM; Coco RM; García-Arumí J; Xu X; Zlateva G
    Curr Med Res Opin; 2008 Jul; 24(7):2103-11. PubMed ID: 18547463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration.
    Pondorfer SG; Terheyden JH; Heinemann M; Wintergerst MWM; Holz FG; Finger RP
    Sci Rep; 2019 Oct; 9(1):15326. PubMed ID: 31653904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration.
    Forshaw TRJ; Parpounas AK; Sørensen TL
    BMC Ophthalmol; 2021 Mar; 21(1):149. PubMed ID: 33757447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of age-related macular degeneration: results of a cohort study in two French referral centres.
    Bonastre J; Le Pen C; Soubrane G; Quentel G
    Pharmacoeconomics; 2003; 21(3):181-90. PubMed ID: 12558468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of costs associated with the management and morbidity of diabetic macular oedema and macular oedema secondary to retinal vein occlusion.
    Abraldes MJ; Pareja A; Roura M;
    Arch Soc Esp Oftalmol; 2016 Jun; 91(6):273-80. PubMed ID: 26810908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Evaluation of Low-Vision Rehabilitation for Veterans With Macular Diseases in the US Department of Veterans Affairs.
    Stroupe KT; Stelmack JA; Tang XC; Wei Y; Sayers S; Reda DJ; Kwon E; Massof RW;
    JAMA Ophthalmol; 2018 May; 136(5):524-531. PubMed ID: 29800250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social Cost of Blindness Due to AMD and Diabetic Retinopathy in the United States in 2020.
    Moshfeghi AA; Lanitis T; Kropat G; Kuznik A; Gibson A; Feng H; Prenner J
    Ophthalmic Surg Lasers Imaging Retina; 2020 Apr; 51(4):S6-S14. PubMed ID: 32348529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-utility analysis of ranibizumab (Lucentis) in neovascular macular degeneration].
    Neubauer AS; Holz FG; Schrader W; Back EI; Kühn T; Hirneiss C; Kampik A
    Klin Monbl Augenheilkd; 2007 Sep; 224(9):727-32. PubMed ID: 17846963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanistic and Economic Burden of Blindness Associated with Retinal Disorders in a Brazilian Sample: A Cross-Sectional Study.
    Lopes N; Dias LLDS; Ávila M; Japiassú RM; Muccioli C; Bordon AF; Arantes TE; Tanaka T; Nassaralla Júnior JJ; Casella AM; Nehemy MB; Ferreira M; Mauad RF
    Adv Ther; 2021 Aug; 38(8):4215-4230. PubMed ID: 33791953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.
    Finger RP; Guymer RH; Gillies MC; Keeffe JE
    Ophthalmology; 2014 Jun; 121(6):1246-51. PubMed ID: 24518613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.